Table 3.
Post-PCI 2-year follow-up of the two groups
| Group | Cases [n (%)] | MACCE [n (%)] | Cardiogenic death [n (%)] | Nonfatal AMI [n (%)] | Ventricular fibrillation [n (%)] | Re- revascularization [n (%)] | Stroke[n(%)] |
|---|---|---|---|---|---|---|---|
| A (n = 210) | 201 (95.7) | 35 (17.4) | 6 (3.0) | 6 (3.0) | 0 | 16 (8.0) | 12 (5.9) |
| B (n = 94) | 89 (94.7) | 6 (6.7)a | 2 (2.2) | 1 (1.1) | 1 (1.1) | 2 (2.2) | 1 (1.1) |
| Group | All-cause death [n (%)] | Re-hospitalization [n (%)] | Recurrence of angina pectoris[n (%)] | Remission of angina pectoris >6 month [n (%)] | Angiographic follow-up [n (%)] | In-stent restenosis (n) |
|---|---|---|---|---|---|---|
| A (n = 210) | 13 (6.5) | 51 (25.4) | 67 (33.3) | 141 (70.1) | 23 (11.4) | 7 |
| B (n = 94) | 3 (3.4) | 9 (10.1)b | 19 (21.3)a | 71 (79.8) | 11 (12.4) | 5 |
MACCE major adverse cardiac cerebrovascular events, AMI acute myocardial infarction
Compared with the A group, a P < 0.05, b P < 0.01